Survival benefit of adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: review of evidence (Q38010511)
Jump to navigation
Jump to search
scientific article published on January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Survival benefit of adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: review of evidence |
scientific article published on January 2012 |
Statements
1 reference
Survival benefit of adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: review of evidence (English)
1 reference
Stefaan Mulier
1 reference
Jean-Pierre Claes
1 reference
Vincent Dierieck
1 reference
Jean-Olivier Amiel
1 reference
Jean-Philippe Pahaut
1 reference
Luc Marcelis
1 reference
Fabienne Bastin
1 reference
Denis Vanderbeeken
1 reference
Claude Finet
1 reference
Sophie Cran
1 reference
Thierry Velu
1 reference
1 January 2012
1 reference
1 reference
Identifiers
1 reference